欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

东南亚制药和医疗保健行业报告(2019-2020年)

Southeast Asia Pharma and Healthcare Sector Report 2019-2020

加工时间:2019-06-26 信息来源:EMIS 索取原文[72 页]
关键词:印度;中国;人均国内生产总值;医疗保健政策和设施;具体要求;药物范围
摘 要:

With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of China being more than twice that of India. In 2017, India reported a fertility rate of 2.1 against only 1.5 for China, suggesting that the Chinese population is ageing at a faster rate compared to that of India. Observed life expectancy for both sexes increased between 1990 and 2017 in both China and India, but as of 2017, China reported higher life expectancy for both men and women compared to India. Thus, China first of the two countries will have to deal with substantial masses of senior population who will pose specific demands on its healthcare policies and facilities, as well as on the range of drugs available in the country. Of the six countries under review, Thailand is home to the most rapidly ageing population. The country reported 15.8% citizens aged 60+ in 2015, a share that is expected to grow to 26.9% in 2030, Global Age Index 2015 data showed. This places the country third in terms of ageing population in Asia, after Japan and South Korea. China ranks fourth.


目 录:

01 EXECUTIVE SUMMARY 

02 INDIA 

03 CHINA 

04 INDONESIA

05 MALAYSIA 

06 THAILAND 

07 THE PHILIPPINES


© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服